Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
FORTIS
Dr. Ashutosh Raghuvanshi · Gurugram, India · 14,649 employees
₹948.85
▼-0.34%Fortis is trading in the upper third of its 1-year range, reflecting a strong institutional support and analyst consensus, amid a healthy 18% YoY revenue growth.
Exchange
NSI
Currency
INR
Day range
₹945.40 – ₹956.00
52-week range
₹766.80 – ₹1,104.30
Sector
Healthcare
Industry
Medical Care Facilities
AI investment rating
AI analysis80% confidence
Fairly valued to slightly overvalued compared to historical range and peers, considering the growth prospects.
14.1% below the 1-year high · trend down
Hedge-fund memo
Today
Trading down around 0.34% today amidst overall market correction. Volume somewhat higher than average.
This week
Continuing consolidation near 52-week high, range-bound for last few weeks.
This month
Showing strong monthly performance, with a price gain of over 5% over last 60 days.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Bullish
24 headlines · 18 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).
3.6583 vs 3.9662
-7.76% surprise
3.0225 vs 3.41815
-11.57% surprise
4.0193 vs 3.56644
12.70% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FORTIS | 716.34B | 68.76 | 11.01% | 16.84% | 17.80% |
| APOLLOHOSP | 1.29T | 66.62 | 21.50% | 11.91% | 18.10% |
| IPCALAB | 446.21B | 39.18 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Intense competition from newer hospital chains and private labels in health services
Mitigation: Focus on tertiary care and maintaining high-quality services
Regulatory challenges in terms of license renewals, permits and healthcare policy impacts
Mitigation: Maintaining open communication with authorities and investing in lobbying where necessary
Higher than anticipated interest costs amidst interest rate hikes
Mitigation: Maintaining liquidity buffers and debt restructuring discussions
Business intelligence
Competitive moat
Durable advantage lies in its diversified hospital network and the strong brand recognition, allowing it to command better pricing and attract high-quality talent
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Revenue growth confirmation and improved cash flow from operations
Thesis builder
Bull case
Expect 20% YoY EPS growth amidst strong revenue traction and controlled cost management
Base case
Expect moderate growth, around 10-12% YoY EPS, with some volatility around key events.
Bear case
Expect 5-8% EPS contraction amidst intense competition and potential regulatory hurdles.
Time horizon
3-5 years
Est. CAGR
12-15%
Entry (qual.)
On a correction towards psychological support levels, around the lower end of the 1-year chart range
Exit (qual.)
When EPS growth slows down meaningfully, suggesting that competition and regulatory environment is intensifying
Overall conviction 80%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how FORTIS fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain FORTIS for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Wait for short term correction to accumulate with a view to long term gains.
Investing.com India·just now·utilities business growth
scanx.trade·4h ago
The Indian Practitioner·6h ago·success of new operations
InvestyWise·7h ago·announces meeting
TipRanks·9h ago·paying out dividends
Stock Titan·9h ago·paying out dividends
marketscreener.com·13h ago·pays third quarter dividends
The Manila Times·20h ago·paying out dividends
Stock Titan·20h ago·paying out dividends
Yahoo Finance·22h ago
MarketWatch·23h ago·market failure
The Australian·23h ago·large investment in Brisbane
NT News·1d ago·market opportunity in Brisbane
Kalkine Media·1d ago·reinforces dividend stability
TradingView·1d ago
scanx.trade·1d ago·shareholder approval for management
Castanet·1d ago·restores power services
Castanet·1d ago·customers experience outages
The Indian Practitioner·1d ago·reappoints successful MD
Castanet·1d ago·customers experience outages
TradingKey·1d ago
The Daily Star·1d ago·successful collaboration
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
3.3226 vs 2.77124
19.90% surprise
| 13.22% |
| 18.48% |
| 6.30% |
| GLENMARK | 618.10B | 45.47 | 14.07% | 16.30% | 14.30% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹945.40
Resistance (day/52w high)
₹956.00
Volume
3,28,839
Trend
down
RSI (14)
50
MACD
bearish
MA cross
golden
50-day MA
₹961.24
200-day MA
₹918.62
vs 200-DMA
3.3%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.